retaglutide is the next gen (3rd) GLP-1 which is in phase 3 trials now. It is a triple antagonist (current are dual GLP-1/GIP). It adds glucagon, and apparently that comes with not only greatly increased weightloss, but also wicked sugar cravings.
These things do way way more than just appetite and craving suppression.
These things do way way more than just appetite and craving suppression.